Vericel Corp (VCEL)

Healthcare Pharmaceuticals & Medical Research Pharmaceuticals

Track Share on 𝕏

Stock chart
Ticker: VCEL Exchange: NAS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-05-17 2024-05-16 PS Planned sale

Colangelo Dominick

President and CEO

Executive Director
1,000 -7.3%
47.85
100,000 USD 		1,000 -7.3% 47.85 100,000 USD
2024-05-17 2024-05-15 PS Planned sale

Colangelo Dominick

President and CEO

Executive Director
1,000 -7.3%
49.67
100,000 USD 		1,000 -7.3% 49.67 100,000 USD
2024-04-19 2024-04-18 PS Planned sale

Colangelo Dominick

President and CEO

Executive Director
17,500 -8.2%
44.59
780,325 USD 		17,500 -8.2% 44.59 780,325 USD
2024-04-19 2024-04-17 PS Planned sale

Colangelo Dominick

President and CEO

Executive Director
17,500 -8.2%
46.47
813,225 USD 		17,500 -8.2% 46.47 813,225 USD
2024-03-29 2024-03-27 PS Planned sale

ZERBE ROBERT L MD

Non-Executive Director
3,278 -12.3%
51.57
169,046 USD 		3,278 -12.3% 51.57 169,046 USD
2024-03-15 2024-03-14 PS Planned sale

Colangelo Dominick

President and CEO

Executive Director
17,500 -8.2%
44.02
770,350 USD 		17,500 -8.2% 44.02 770,350 USD
2024-03-15 2024-03-13 PS Planned sale

Colangelo Dominick

President and CEO

Executive Director
17,500 -8.2%
44.67
781,725 USD 		17,500 -8.2% 44.67 781,725 USD
2024-03-13 2024-03-11 PS Planned sale

Halpin Michael

Chief Operating Officer

Officer
7,874 -89.2%
44.71
352,047 USD 		7,874 -89.2% 44.71 352,047 USD
2024-03-11 2024-03-08 PS Planned sale

Flynn Sean C.

SVP, General Counsel

Officer
8,115 -98.0%
45.33
367,853 USD 		8,115 -98.0% 45.33 367,853 USD
2024-03-11 2024-03-07 PS Planned sale

SIEGAL JONATHAN

Principal Accounting Officer

Officer
1,634 -53.9%
45.00
73,530 USD 		1,634 -53.9% 45.00 73,530 USD
2024-02-22 2024-02-20 PS Planned sale

ZERBE ROBERT L MD

Non-Executive Director
722 -3.0%
50.01
36,107 USD 		722 -3.0% 50.01 36,107 USD
2024-02-16 2024-02-15 PS Planned sale

Colangelo Dominick

President and CEO

Executive Director
17,500 -9.1%
48.85
854,875 USD 		17,500 -9.1% 48.85 854,875 USD
2024-02-16 2024-02-14 PS Planned sale

Colangelo Dominick

President and CEO

Executive Director
17,500 -9.1%
46.99
822,325 USD 		17,500 -9.1% 46.99 822,325 USD
2024-01-30 2024-01-29 PS Planned sale

ZERBE ROBERT L MD

Non-Executive Director
2,300 -9.0%
44.22
101,706 USD 		2,300 -9.0% 44.22 101,706 USD
2024-01-29 2024-01-25 PS Planned sale

ZERBE ROBERT L MD

Non-Executive Director
200 -0.8%
44.02
8,804 USD 		200 -0.8% 44.02 8,804 USD
2024-01-24 2024-01-22 PS Planned sale

ZERBE ROBERT L MD

Non-Executive Director
3,000 -10.4%
42.05
126,150 USD 		3,000 -10.4% 42.05 126,150 USD
2024-01-24 2024-01-22 PS Planned sale

ZERBE ROBERT L MD

Non-Executive Director
2,500 -8.8%
42.06
105,150 USD 		2,500 -8.8% 42.06 105,150 USD
2024-01-24 2024-01-22 PS Planned sale

ZERBE ROBERT L MD

Non-Executive Director
2,500 -8.1%
41.39
103,475 USD 		2,500 -8.1% 41.39 103,475 USD
2024-01-19 2024-01-18 PS Planned sale

Colangelo Dominick

President and CEO

Executive Director
16,726 -9.0%
38.58
645,289 USD 		16,726 -9.0% 38.58 645,289 USD
2024-01-19 2024-01-17 PS Planned sale

Colangelo Dominick

President and CEO

Executive Director
16,726 -9.0%
37.97
635,086 USD 		16,726 -9.0% 37.97 635,086 USD
2024-01-16 2024-01-12 PS Planned sale

ZERBE ROBERT L MD

Non-Executive Director
2,200 -6.6%
38.09
83,798 USD 		2,200 -6.6% 38.09 83,798 USD
2023-12-15 2023-12-14 S Sale

Wotton Paul K

Non-Executive Director
5,000 -15.7%
37.31
186,550 USD 		5,000 -15.7% 37.31 186,550 USD
2023-12-15 2023-12-14 PS Planned sale

Flynn Sean C.

SVP, General Counsel

Officer
106 -2.3%
37.45
3,970 USD 		106 -2.3% 37.45 3,970 USD
2023-12-15 2023-12-14 PS Planned sale

Colangelo Dominick

President and CEO

Executive Director
12,000 -6.6%
37.12
445,440 USD 		12,000 -6.6% 37.12 445,440 USD
2023-12-15 2023-12-13 PS Planned sale

Flynn Sean C.

SVP, General Counsel

Officer
1,432 -23.8%
34.20
48,974 USD 		1,432 -23.8% 34.20 48,974 USD
2023-12-15 2023-12-13 PS Planned sale

Colangelo Dominick

President and CEO

Executive Director
12,000 -6.6%
34.03
408,360 USD 		12,000 -6.6% 34.03 408,360 USD
2023-12-08 2023-12-07 PS Planned sale

Colangelo Dominick

President and CEO

Executive Director
12,000 -6.4%
33.84
406,080 USD 		12,000 -6.4% 33.84 406,080 USD
2023-12-08 2023-12-06 PS Planned sale

Colangelo Dominick

President and CEO

Executive Director
12,397 -6.6%
34.43
426,829 USD 		12,397 -6.6% 34.43 426,829 USD
2023-12-01 2023-11-30 PS Planned sale

Halpin Michael

Chief Operating Officer

Officer
17,447 -95.5%
35.41
617,798 USD 		17,447 -95.5% 35.41 617,798 USD
2023-11-22 2023-11-20 PS Planned sale

Hopper Jonathan Mark

Chief Medical Officer

Officer
5,000 -8.6%
36.40
182,000 USD 		5,000 -8.6% 36.40 182,000 USD
2023-11-17 2023-11-15 PS Planned sale

ZERBE ROBERT L MD

Non-Executive Director
100 -0.3%
38.06
3,806 USD 		100 -0.3% 38.06 3,806 USD
2023-11-17 2023-11-15 PS Planned sale

ZERBE ROBERT L MD

Non-Executive Director
200 -0.6%
38.00
7,600 USD 		200 -0.6% 38.00 7,600 USD
2023-11-17 2023-11-15 PS Planned sale

SIEGAL JONATHAN

Principal Accounting Officer

Officer
662 -33.7%
37.70
24,954 USD 		662 -33.7% 37.70 24,954 USD
2023-07-17 2023-07-14 PS Planned sale

ZERBE ROBERT L MD

Non-Executive Director
1,000 -2.9%
38.84
38,840 USD 		1,000 -2.9% 38.84 38,840 USD
2023-06-26 2023-06-22 PS Planned sale

ZERBE ROBERT L MD

Non-Executive Director
3,000 -8.0%
36.00
108,000 USD 		3,000 -8.0% 36.00 108,000 USD
2023-02-03 2023-02-02 PS Planned sale

SIEGAL JONATHAN

Principal Accounting Officer

Officer
330 -32.8%
31.00
10,230 USD 		330 -32.8% 31.00 10,230 USD
2023-01-12 2023-01-10 PS Planned sale

Colangelo Dominick

President and CEO

Executive Director
39,938 -20.3%
27.13
1,083,598 USD 		39,938 -20.3% 27.13 1,083,598 USD
2022-10-18 2022-10-14 PS Planned sale

SIEGAL JONATHAN

Principal Accounting Officer

Officer
331 -27.4%
25.47
8,431 USD 		331 -27.4% 25.47 8,431 USD
2022-05-02 2022-04-29 PS Planned sale

GILMAN STEVEN C

Non-Executive Director
900 -14.8%
30.94
27,846 USD 		900 -14.8% 30.94 27,846 USD
2022-03-03 2022-03-01 PS Planned sale

Hopper Jonathan Mark

Chief Medical Officer

Officer
6,738 -12.1%
41.46
279,371 USD 		6,738 -12.1% 41.46 279,371 USD
2022-03-03 2022-03-01 PS Planned sale

Hopper Jonathan Mark

Chief Medical Officer

Officer
10,000 -17.9%
41.41
414,060 USD 		10,000 -17.9% 41.41 414,060 USD
2021-12-22 2021-12-22 PS Planned sale

Hopper Jonathan Mark

Chief Medical Officer

Officer
5,881 -11.9%
40.08
235,692 USD 		5,881 -11.9% 40.08 235,692 USD
2021-12-22 2021-12-22 PS Planned sale

Hopper Jonathan Mark

Chief Medical Officer

Officer
9,000 -18.6%
40.14
361,238 USD 		9,000 -18.6% 40.14 361,238 USD
2021-12-22 2021-12-20 PS Planned sale

Hopper Jonathan Mark

Chief Medical Officer

Officer
1,000 -2.5%
40.00
40,000 USD 		1,000 -2.5% 40.00 40,000 USD
2021-12-01 2021-11-29 PS Planned sale

GILMAN STEVEN C

Non-Executive Director
5,000 -58.8%
39.17
195,855 USD 		5,000 -58.8% 39.17 195,855 USD
2021-10-28 2021-10-27 PS Planned sale

GILMAN STEVEN C

Non-Executive Director
5,000 -58.8%
50.57
252,870 USD 		5,000 -58.8% 50.57 252,870 USD
2021-10-28 2021-10-26 PS Planned sale

Halpin Michael

Chief Operating Officer

Officer
10,000 -63.7%
50.57
505,689 USD 		10,000 -63.7% 50.57 505,689 USD
2021-10-01 2021-09-30 PS Planned sale

GILMAN STEVEN C

Non-Executive Director
5,000 -58.8%
48.85
244,255 USD 		5,000 -58.8% 48.85 244,255 USD
2021-05-17 2021-05-14 S Sale

Wotton Paul K

Non-Executive Director
5,000 -15.8%
50.52
252,611 USD 		5,000 -15.8% 50.52 252,611 USD
2021-05-13 2021-05-12 S Sale

Wotton Paul K

Non-Executive Director
2,200 -6.5%
48.88
107,534 USD 		2,200 -6.5% 48.88 107,534 USD
2021-05-13 2021-05-11 S Sale

Wotton Paul K

Non-Executive Director
13,448 -28.5%
50.11
673,922 USD 		13,448 -28.5% 50.11 673,922 USD
2021-03-30 2021-03-29 PS Planned sale

Colangelo Dominick

President and CEO

Executive Director
13,125 -7.3%
50.94
668,588 USD 		13,125 -7.3% 50.94 668,588 USD
2021-03-30 2021-03-29 PS Planned sale

Colangelo Dominick

President and CEO

Executive Director
10,313 -5.4%
50.93
525,241 USD 		10,313 -5.4% 50.93 525,241 USD
2021-03-30 2021-03-29 PS Planned sale

Colangelo Dominick

President and CEO

Executive Director
15,552 -7.5%
51.09
794,552 USD 		15,552 -7.5% 51.09 794,552 USD
2021-03-30 2021-03-29 PS Planned sale

Colangelo Dominick

President and CEO

Executive Director
1,010 -0.5%
51.36
51,874 USD 		1,010 -0.5% 51.36 51,874 USD
2021-03-02 2021-03-01 PS Planned sale

Colangelo Dominick

President and CEO

Executive Director
8,692 -4.0%
48.01
417,303 USD 		8,692 -4.0% 48.01 417,303 USD
2021-03-02 2021-03-01 PS Planned sale

Colangelo Dominick

President and CEO

Executive Director
27,500 -11.3%
48.06
1,321,650 USD 		27,500 -11.3% 48.06 1,321,650 USD
2021-03-02 2021-03-01 PS Planned sale

Colangelo Dominick

President and CEO

Executive Director
2,260 -1.0%
48.78
110,243 USD 		2,260 -1.0% 48.78 110,243 USD
2021-03-02 2021-03-01 PS Planned sale

Colangelo Dominick

President and CEO

Executive Director
1,548 -0.7%
48.47
75,032 USD 		1,548 -0.7% 48.47 75,032 USD
2020-12-23 2020-12-21 PS Planned sale

Halpin Michael

Chief Operating Officer

Officer
30,000 -92.9%
26.28
788,400 USD 		30,000 -92.9% 26.28 788,400 USD
2020-12-23 2020-12-21 PS Planned sale

Hopper Jonathan Mark

Chief Medical Officer

Officer
11,709 -33.4%
26.61
311,541 USD 		11,709 -33.4% 26.61 311,541 USD
2020-12-23 2020-12-21 PS Planned sale

Hopper Jonathan Mark

Chief Medical Officer

Officer
7,526 -33.3%
26.61
200,244 USD 		7,526 -33.3% 26.61 200,244 USD
2020-12-23 2020-12-21 PS Planned sale

Hopper Jonathan Mark

Chief Medical Officer

Officer
5,000 -53.6%
26.27
131,374 USD 		5,000 -53.6% 26.27 131,374 USD
2020-11-24 2020-11-23 S Sale

ZERBE ROBERT L MD

Non-Executive Director
17,500 -35.5%
23.55
412,125 USD 		17,500 -35.5% 23.55 412,125 USD
2020-06-24 2020-06-23 PS Planned sale

Halpin Michael

Chief Operating Officer

Officer
14,751 -90.1%
15.01
221,413 USD 		14,751 -90.1% 15.01 221,413 USD
2020-06-18 2020-06-16 PS Planned sale

Halpin Michael

Chief Operating Officer

Officer
1,112 -40.7%
15.00
16,680 USD 		1,112 -40.7% 15.00 16,680 USD
2020-06-18 2020-06-16 PS Planned sale

Halpin Michael

Chief Operating Officer

Officer
2,890 -51.4%
15.00
43,350 USD 		2,890 -51.4% 15.00 43,350 USD
2019-11-12 2019-11-11 PS Planned sale

Halpin Michael

Chief Operating Officer
15,047 -93.6%
18.53
278,821 USD 		15,047 -93.6% 18.53 278,821 USD
2019-10-03 2019-10-01 PS Planned sale

Colangelo Dominick

President and CEO
58,125 -34.0%
14.88
864,650 USD 		58,125 -34.0% 14.88 864,650 USD
2019-08-16 2019-08-14 PS Planned sale

MICHEL GERARD J

CFO and VP, Corp. Development
17,000 -12.1%
16.62
282,547 USD 		17,000 -12.1% 16.62 282,547 USD
2019-07-17 2019-07-15 PS Planned sale

MICHEL GERARD J

CFO and VP, Corp. Development
17,000 -12.1%
19.68
334,579 USD 		17,000 -12.1% 19.68 334,579 USD
2019-06-12 2019-06-10 PS Planned sale

MICHEL GERARD J

CFO and VP, Corp. Development
8,750 -6.7%
15.53
135,863 USD 		8,750 -6.7% 15.53 135,863 USD
2019-06-12 2019-06-10 PS Planned sale

MICHEL GERARD J

CFO and VP, Corp. Development
8,750 -6.2%
15.72
137,510 USD 		8,750 -6.2% 15.72 137,510 USD
2019-05-14 2019-05-13 PS Planned sale

MICHEL GERARD J

CFO and VP, Corp. Development
17,500 -12.5%
17.02
297,859 USD 		17,500 -12.5% 17.02 297,859 USD
2019-05-03 2019-05-01 PS Planned sale

GILMAN STEVEN C

7,500 -100.0%
16.81
126,095 USD 		7,500 -100.0% 16.81 126,095 USD